Condiciones de salud que carrapichinho puede ayudar a apoyar.
Vitamin D deficiency is significantly more common in acne patients (standardized mean difference -7.66 ng/mL vs. non-acne controls, per systematic review). Vitamin D supplementation in deficient acne patients reduces sebum production, inhibits C. acnes development, and decreases inflammatory lesions. A good-quality clinical study was identified in a nutraceutical systematic review (42 studies, 3,346 participants).
The NIDDK (National Institutes of Health) specifically recommends that Addison's disease patients on corticosteroid replacement therapy obtain adequate vitamin D and calcium to protect against corticosteroid-induced osteoporosis. A pilot trial (Penna-Martinez et al., Nutrition, 2018) investigated high-dose vitamin D in Addison's disease patients and found immunomodulatory effects on T-cells and monocytes. A systematic review (Frontiers in Endocrinology, 2022) documents correlations between vitamin D status and Addison's disease, including shared autoimmune pathways.
Vitamin D modulates Th1/Th2 immune balance, inhibits IL-5 and IL-13 production, and vitamin D deficiency correlates with increased allergic rhinitis severity and elevated IgE. A 2025 systematic review and meta-analysis found adjuvant vitamin D supplementation significantly reduced total nasal symptom scores (TNSS) and IgE levels in allergic rhinitis patients. A 2024 systematic review also confirmed heterogeneous but mostly positive effects of vitamin D on AR symptom outcomes.
ALS patients have significantly lower serum 25-hydroxyvitamin D levels than controls, and a Mendelian randomization study found higher genetically predicted vitamin D levels associated with reduced ALS risk. A systematic review of 13 studies found discordant results for vitamin D supplementation on ALS outcomes, with some showing small functional improvement. The relationship is under active investigation.
Vitamin D receptors (VDR) are expressed in Leydig and Sertoli cells of the testes, suggesting a direct role in testosterone production. Observational studies consistently show positive correlation between 25(OH)D levels and testosterone in aging men. Intervention trials suggest that vitamin D supplementation improves testosterone and sexual hormones primarily in vitamin D-deficient men (hypovitaminosis D), which is common in aging male populations.
Vitamin D may improve endothelial function, reduce arterial stiffness, and decrease atherosclerosis risk by inhibiting the renin-angiotensin-aldosterone system and reducing vascular inflammation. A 2022 network meta-analysis included vitamin D3 (cholecalciferol) among vitamin supplements assessed for arterial stiffness reduction via PWV. Multiple observational studies associate vitamin D deficiency with increased arterial stiffness.
Vitamin D plays a role in bone metabolism, immune regulation, and chondrocyte function relevant to arthritis. Vitamin D deficiency is associated with increased OA and RA severity. RCTs assessing vitamin D supplementation in arthritis show variable results, but the Arthritis Foundation includes it among studied supplements, and NCCIH references its role in bone health and immune regulation in arthritis contexts.
Vitamin D deficiency has been consistently associated with increased asthma exacerbations and reduced lung function. Multiple RCTs and meta-analyses support its role in reducing asthma attack frequency and modulating immune responses. A 2024 RCT in adults with mild-to-moderate asthma found vitamin D3 supplementation significantly improved FEV1:FVC ratio compared to placebo.
Multiple observational and interventional studies show that children with ADHD have lower vitamin D levels, and RCTs combining vitamin D with magnesium found significant improvements in ADHD behavior scores. A clinical study found that increases in serum 25(OH)D from supplementation correlated with improvement in ADHD inattention symptoms.
Vitamin D has robust scientific evidence as an immunomodulator relevant to autoimmune disease prevention and management. The VITAL trial showed 2000 IU/day reduced new autoimmune disease incidence by 22% over 5 years. Clinical trials have been conducted in MS, RA, Crohn's disease, type 1 diabetes, and SLE. Vitamin D regulates T-regulatory cells, suppresses T-cell proliferation, and modulates macrophage function.
Vitamin D deficiency is consistently and significantly associated with increased low back pain severity, paraspinal muscle atrophy, and lumbar disc degeneration. A retrospective study (n=232 postmenopausal women) found severe deficiency correlated with higher VAS pain scores (p=0.002) and more severe disc degeneration at multiple lumbar levels. Mechanistically, vitamin D inhibits NF-κB and ferroptosis in nucleus pulposus cells and supports musculoskeletal function.
A 2025 systematic review and meta-analysis published in BMC Neurology found an association between lower serum vitamin D levels and Bell's palsy incidence and severity. Vitamin D acts as a neuro-immunomodulator, and multiple studies have examined its role in facial nerve dysfunction. Evidence suggests vitamin D deficiency may be a risk factor, with supplementation considered potentially supportive.
Vitamin D has emerging clinical evidence linking deficiency to overactive bladder and urinary incontinence. A 2024 systematic review and meta-analysis (Nutrition Reviews) found vitamin D levels inversely associated with OAB risk. A 2023 RCT showed vitamin D supplementation improved urgent urinary incontinence in postmenopausal women. Vitamin D receptors are expressed in detrusor muscle and urothelium.
Vitamin D is critical for calcium absorption and bone mineralization. Deficiency causes rickets in children and osteomalacia in adults. Combined calcium and vitamin D supplementation has been shown in RCTs to attenuate bone loss at the hip and lumbar spine, and vitamin D deficiency is strongly associated with lower BMD and higher fracture risk.
Vitamin D deficiency is strongly associated with cognitive impairment and brain fog. Vitamin D receptors are distributed throughout the brain, and vitamin D modulates neurotrophin synthesis, neuroinflammation, and neurotransmitter function. Multiple studies show low vitamin D correlates with depressive symptoms and cognitive deficits, while supplementation can improve both—including the concentration and memory difficulties characteristic of brain fog.
Vitamin D is cited by Severn Pain and Injury Care for bursitis, with research showing correlation between low vitamin D and increased inflammation. It exerts anti-inflammatory effects through regulation of cytokines and inhibition of NF-κB and prostaglandins. A meta-analysis confirmed vitamin D supplementation reduces high-sensitivity CRP, a marker of inflammation.
Vitamin D deficiency has been identified as an independent risk factor for CTS severity and pain. A 2021 systematic review of four studies found that vitamin D supplementation improved pain scores, nerve conduction velocity, and functional status in CTS patients. A 2024 RCT further confirmed clinical and electroneuromyographic improvements with adjuvant vitamin D.
Vitamin D (1,25-dihydroxyvitamin D3) regulates cartilage matrix synthesis via vitamin D receptors on chondrocytes, protecting against cartilage degradation. Low vitamin D status is consistently associated with greater OA severity and faster cartilage loss in epidemiological studies. A 2022 network meta-analysis included vitamin D among top supplements for knee OA pain outcomes, and European OA guidelines recommend correcting vitamin D deficiency in OA patients.
Vitamin D deficiency is among the most common micronutrient deficiencies in both newly diagnosed and treated celiac disease, arising from malabsorption of fat-soluble vitamins. The 2013 ACG guidelines and 2015 UK NICE guidelines recommend screening and supplementing vitamin D in CeD patients. Supplementation combined with calcium is specifically endorsed when GFD alone does not normalize bone mineral density.
Vitamin D is essential for calcium and phosphate metabolism, enabling proper bone mineralization and skeletal development in children. Severe deficiency causes rickets, a well-documented pediatric condition characterized by soft, deformed bones. Evidence indicates subclinical vitamin D deficiency impairs bone mineral density accrual during childhood and adolescence.
Vitamin D is critical for immune regulation in children, with deficiency strongly associated with increased susceptibility to respiratory infections. A major 2017 BMJ meta-analysis of 25 RCTs found vitamin D supplementation protected against acute respiratory infections, with the strongest benefit in deficient individuals. Year-round supplementation of 400–1,000 IU/day is recommended for most children.
Vitamin D is one of the most important ingredients in children's MVMs, with an NIH ODS-established RDA of 400–600 IU/day for children. It is critical for calcium absorption, bone development, and immune regulation. NIH ODS-funded label analysis confirms it appears in the majority of children's MVMs.
Vitamin D deficiency is strongly and consistently associated with fatigue, muscle weakness, and low energy across multiple observational studies and clinical trials. Supplementation in deficient individuals significantly improves fatigue. It is among the most common nutrient deficiencies linked to fatigue and is recognized by NIH and Harvard Health as a key micronutrient in this context.
Substantial clinical and mechanistic evidence supports a role for vitamin D in modulating chronic inflammation. Vitamin D deficiency is causally linked to elevated C-reactive protein (CRP), a primary biomarker of systemic inflammation, with correction of deficiency reducing CRP levels. Multiple meta-analyses of randomized controlled trials confirm that supplementation significantly reduces key pro-inflammatory markers including CRP, TNF-α, and IL-6, though benefits appear strongest in those with pre-existing deficiency. Evidence spans diverse chronically inflamed populations including patients with metabolic disease, respiratory disease, and cancer.
Vitamin D deficiency is significantly associated with chronic musculoskeletal pain and fibromyalgia. A systematic review of 14 RCTs found that vitamin D supplementation reduces pain in deficient patients. It modulates inflammatory cytokines (TNF-α, IL-17) and suppresses central sensitization pathways relevant to chronic pain.
Vitamin D supplementation reduces risk of acute respiratory infections, particularly in deficient individuals. A 2017 Cochrane meta-analysis of 25 RCTs (>11,000 participants) found it reduced ARI risk overall, with greatest benefit in those severely deficient. NCCIH notes that correcting deficiency may help prevent flu and other respiratory infections. Mechanism involves induction of cathelicidin and defensins in respiratory epithelium.
Vitamin D supplementation has been tested in a randomized clinical trial in UC patients with vitamin D deficiency (hypovitaminosis D), showing increased vitamin D levels over 90 days. Systematic reviews support vitamin D's role in intestinal barrier integrity, VDR-mediated anti-inflammatory signaling, and promoting butyrate-producing commensal bacteria in UC.
Vitamin D deficiency is common in TBI patients and correlates with worse recovery outcomes. A clinical study found vitamin D supplementation (versus control) significantly improved MMSE scores (p=0.045) and overall recovery rate over 12 weeks after mild-to-moderate TBI. A 2024 Nutritional Neuroscience review confirms vitamin D supplementation improves cognitive function and correlates with better TBI recovery. Multiple systematic reviews classify it as one of the fat-soluble vitamins with the strongest evidence in mTBI nutritional interventions.
Vitamin D deficiency is prevalent in COPD patients and linked to increased exacerbation risk and impaired immune function. A systematic review and meta-analysis found vitamin D supplementation alone improved lung function (FEV1, FEV1/FVC) in COPD patients. An RCT in 120 COPD patients showed clinical improvement with calcitriol. Multiple authoritative reviews support vitamin D as protective against COPD progression.
Vitamin D deficiency is highly prevalent in Crohn's disease and linked to disease severity and relapse risk. Gastroenterologists routinely recommend supplementation to correct deficiency, support bone health, and modulate intestinal immune function. Higher serum vitamin D levels correlate with improved remission rates in CD.
Vitamin D deficiency is strongly associated with depression, and multiple systematic reviews find supplementation modestly improves depressive symptoms. A meta-analysis of adjunctive nutraceuticals (American Journal of Psychiatry) identified primarily positive results for vitamin D in replicated studies. It is included in CANMAT/WFSBP 2022 guidelines as a Grade A adjunct for MDD.
Vitamin D supplementation for atopic dermatitis is supported by a 2024 meta-analysis of 11 RCTs (686 participants) showing significant SCORAD/EASI reduction (standardized mean difference −0.41, 95% CI: −0.67 to −0.16, p<0.01). Lower serum vitamin D levels correlate with greater AD severity, and supplementation shows adjuvant therapeutic benefit.
Vitamin D (cholecalciferol/calciferol) is FDA conditionally approved as a healing agent in diaper rash preparations, delivered via cod liver oil or as pure cholecalciferol. Multiple OTC diaper rash products (DailyMed) list vitamin D as an inactive ingredient. It supports skin barrier function and immune modulation.
Vitamin D has a regulatory role in skin barrier function and immune modulation directly relevant to eczema pathogenesis. A meta-analysis of nine RCTs found significant SCORAD improvement in atopic dermatitis patients supplemented with vitamin D. Low vitamin D levels are consistently associated with worse eczema severity.
Lower circulating vitamin D levels are consistently associated with higher endometriosis risk and severity. Multiple RCTs have assessed vitamin D supplementation for endometriosis-associated pain, yielding mixed results—significant pain changes were observed but often comparable to placebo. Vitamin D has immunomodulatory and anti-inflammatory properties directly relevant to endometriosis pathophysiology.
Vitamin D deficiency is independently associated with muscle fatigue, weakness, and reduced energy. Correction of low vitamin D levels has been shown in RCTs to significantly improve fatigue outcomes. Vitamin D receptors are present in muscle tissue, and vitamin D is involved in mitochondrial function and oxidative phosphorylation.
Vitamin D receptors are expressed in sperm cells, Sertoli cells, and Leydig cells. Low serum 25(OH)D levels are associated with reduced sperm motility, morphology, and testosterone in observational studies. Mechanistic studies show calcitriol regulates calcium-mediated sperm motility and testosterone production. Clinical trial results are mixed, with benefits most likely in vitamin D-deficient men.
Low vitamin D levels are associated with reduced oocyte quality, impaired ovarian reserve, and poorer IVF outcomes. Multiple systematic reviews document that vitamin D supplementation is among the interventions increasing clinical pregnancy rates in infertile women. Evidence is strongest in vitamin D-deficient women undergoing ART.
Vitamin D deficiency is commonly found in FM patients and correlates inversely with pain severity and FIQ scores. A 2025 systematic review and meta-analysis found vitamin D supplementation significantly reduced pain levels compared to control, with effect sizes of SMD −0.85 on NRS/VAS (p=0.0148) and SMD −0.87 on FIQ scale (p=0.0115). A 2017 meta-analysis also concluded vitamin D is a determinant factor in FM.
Vitamin D is an essential fat-soluble vitamin whose deficiency is strongly associated with increased joint pain, muscle weakness, and impaired musculoskeletal function. Multiple clinical studies and meta-analyses document associations between low vitamin D and worsened OA outcomes, and supplementation has been shown to improve muscle strength and physical function relevant to joint mobility.
Multiple studies document lower vitamin D levels in children with ADHD versus controls. A 2019 RCT found vitamin D supplementation improved attention, impulsivity, and hyperactivity in children with ADHD and vitamin D deficiency. A network meta-analysis of 48 ADHD pediatric studies (n=3,650) ranked vitamin D among the top three most effective nutrient interventions for total ADHD symptom scores.
Vitamin D contributes to immune tolerance and intestinal epithelial barrier integrity relevant to food allergy. Laboratory studies confirm vitamin D modulates food allergy immune regulation; clinical studies link vitamin D deficiency to increased food allergen sensitization and atopic dermatitis severity. It promotes Treg cell activity and mucosal immune tolerance that prevents aberrant allergic sensitization to food antigens.
Vitamin D has been examined in multiple RCTs and systematic reviews for its role in periodontal health. A 2023 systematic review concluded vitamin D may serve as a beneficial adjunct to periodontal therapy, particularly in deficient individuals. Its mechanisms include modulation of bone metabolism (critical to alveolar bone), anti-inflammatory effects, and enhancement of innate immune defense against periodontal pathogens.
Vitamin D and its receptor (VDR) are expressed in hair follicles and play a role in follicular cycling. Deficiency of vitamin D is associated with androgenetic alopecia, alopecia areata, and telogen effluvium across numerous studies. A 2022 RCT found oral vitamin D supplementation combined with topical minoxidil yielded better results than either treatment alone in female pattern hair loss.
Vitamin D receptors are expressed in hair follicles and play a role in regulating the hair cycle. Deficiency in vitamin D has been associated with alopecia areata and androgenetic alopecia in multiple studies. Clinical guidelines support supplementation in patients with documented vitamin D deficiency presenting with non-scarring hair loss.
Vitamin D is a steroid hormone with widespread genomic effects critical for immune regulation, bone health, cellular repair, and cardiovascular function, all impaired in aging. Multiple systematic reviews, the VITAL trial, and 2025 data link vitamin D supplementation to telomere protection, reduced all-cause mortality, and improved healthspan in older adults. NIH ODS identifies it as a key nutrient for healthy aging.
Vitamin D is essential for calcium and phosphorus metabolism and bone mineralization in children, with severe deficiency causing rickets—characterized by poor statural growth and bone deformity. The American Academy of Pediatrics (AAP) recommends vitamin D supplementation for all breastfed infants. Clinical evidence shows that the GH/IGF-1 axis, the primary axis governing statural growth, interacts with vitamin D signaling, with multiple studies demonstrating a relationship between vitamin D status and growth outcomes in children.
Vitamin D deficiency is associated with increased tinnitus loudness and higher risk of sensorineural hearing loss. Clinical trials have shown that correcting vitamin D deficiency can reduce tinnitus severity. Studies evaluating vitamin D supplementation for sudden hearing loss have shown modest benefit at moderate doses. Vitamin D receptors are present in cochlear cells.
Extensive observational data consistently links low serum 25-hydroxyvitamin D with increased risk of hypertension, atherosclerosis, heart failure, and cardiovascular mortality. Biologically, vitamin D modulates cardiomyocyte calcium handling, endothelial function, vascular smooth muscle, inflammation, and the renin–angiotensin–aldosterone system. However, large randomized controlled trials—including the landmark VITAL trial (25,871 participants, 2,000 IU/day vitamin D3)—have not demonstrated that supplementation reduces major cardiovascular events. The overall picture is one of strong biological plausibility and consistent epidemiological association, but unproven causality from interventional evidence.
Several studies link vitamin D deficiency to menstrual cycle disorders including heavy bleeding. A 2023 double-blind RCT (Amzajerdi et al., BMC Women's Health) found that a single high-dose vitamin D supplementation significantly reduced menstrual blood loss in young women with primary dysmenorrhea and vitamin D deficiency. Vitamin D also slows fibroid growth, a common cause of menorrhagia, according to a 2023 systematic review.
Vitamin D deficiency is prevalent in Hashimoto's thyroiditis and is mechanistically linked to impaired VDR-mediated Treg/Th17 immune balance, increasing anti-TPO antibody production. A 2021 meta-analysis of 8 RCTs (n=652) found vitamin D supplementation significantly reduced both TPOAb and TGAb titers in HT patients. Supplementation doses of 2,000–4,000 IU/day for >3 months show the most consistent effects.
Vitamin D deficiency is consistently associated with increased IBD risk, disease severity, and relapse rates in both UC and CD. Vitamin D supplementation has been studied in IBD clinical trials, with evidence suggesting it may help maintain remission in CD and reduce inflammatory markers in IBD patients.
Vitamin D influences intestinal barrier function through vitamin D receptors (VDR) expressed in intestinal epithelial cells, modulating tight junction protein expression and mucosal immune signaling. A short-term RCT in Crohn's disease patients (2,000 IU/day for 3 months) showed vitamin D may improve gastroduodenal permeability. A Mayo Clinic-registered clinical trial (NCT01640496) specifically investigated vitamin D's effect on colonic permeability and tight junction protein expression in ulcerative colitis.
Vitamin D receptors are expressed throughout the brain including in regions critical for learning and memory (hippocampus, prefrontal cortex). Vitamin D deficiency is associated with increased risk of cognitive decline and Alzheimer's disease. A 2024 meta-analysis found vitamin D improves global cognitive function, memory, and attention in MCI patients in RCTs.
Vitamin D has immunomodulatory, anti-inflammatory, and anti-angiogenic properties relevant to AMD pathogenesis. A prospective AREDS-linked study (n=2,146, 9.4-year follow-up) evaluated vitamin D intake and AMD progression. Epidemiological and experimental studies consistently point to vitamin D's role in AMD pathophysiology, and a Japanese case-control study (n=161 AMD cases) found low vitamin D intake significantly associated with neovascular AMD (Trend P=0.002).
Vitamin D, acting via its nuclear vitamin D receptor (VDR) on mast cells, directly suppresses IgE-mediated mast cell activation and inflammatory mediator release. A 2016 peer-reviewed study (PubMed 27998003) concluded vitamin D is required for mast cell stability and that deficiency causes mast cell activation. VDR-dependent calcitriol signaling reduces histamine and leukotriene release from bone marrow-derived and human mast cells.
Vitamin D is critical for calcium absorption and bone health, making it directly relevant to postmenopausal osteoporosis prevention. A comprehensive 2025 systematic review confirmed that vitamin D and calcium together yield clinically meaningful benefits in postmenopausal osteoporosis management. Postmenopausal women are highly susceptible to vitamin D deficiency.
Multiple clinical trials and a 2024 systematic review confirm vitamin D supplementation reduces the severity of primary dysmenorrhea, with a significant effect in meta-analysis (SMD −1.02, p=0.024). Lower serum vitamin D levels are inversely associated with dysmenorrhea severity. Vitamin D modulates calcium absorption and inflammatory cytokine production.
Substantial clinical and observational evidence links low vitamin D status with metabolic syndrome (MetS) and its individual components — insulin resistance, dyslipidemia, hypertension, and abdominal obesity. Multiple RCTs and meta-analyses confirm that vitamin D supplementation can modestly improve select MetS parameters, particularly glycemic indices and blood pressure in deficient individuals, though effects on lipids and body composition are inconsistent. Overall evidence quality ranges from low to moderate, and causality has not been firmly established.
Vitamin D deficiency has been associated with higher migraine incidence. A 2024 systematic review and meta-analysis of RCTs found vitamin D supplementation reduced migraine frequency (MD = −1.69) and monthly migraine days (MD = −2.41). A 2020 RCT also found vitamin D3 combined with topiramate improved pediatric migraine prophylaxis versus topiramate alone.
Vitamin D acts as a nuclear hormone receptor ligand in skeletal muscle, regulating protein synthesis, calcium handling, and inflammatory gene expression. A systematic review and meta-analysis specifically examining vitamin D in post-exercise muscle recovery found anti-inflammatory benefits but limited direct evidence for improved recovery metrics.
Multiple studies confirm significantly lower vitamin D levels in MG patients vs. healthy controls. A 2022 systematic review and meta-analysis (5 studies, n=450) documented statistically significant vitamin D deficiency in MG. A pilot study with 800 IU/day vitamin D3 in 13 MG patients produced a 38% improvement in muscle fatigue and reduced autoimmune markers. A case report documented complete remission in severe refractory MG with high-dose vitamin D therapy.
Vitamin D receptors are expressed throughout the nervous system, and vitamin D plays a documented role in neuroprotection and nerve repair by regulating neurotrophic factors and myelination. Deficiency is strongly associated with peripheral neuropathy and neuropathic pain. A 2025 PRISMA systematic review identified vitamin D alongside B vitamins and E as vitamins with demonstrated benefits in nerve regeneration.
Vitamin D is essential for intestinal calcium absorption and bone mineralization, and is universally recommended alongside calcium for osteoporosis prevention. Clinical guidelines from NIH, IOF, and WHO identify vitamin D deficiency as a major modifiable osteoporosis risk factor. Combined supplementation with calcium significantly increases BMD in postmenopausal women per multiple RCTs.
Vitamin D deficiency is strongly linked to OAB, with a meta-analysis (PubMed PMID 37195440) finding vitamin D–deficient individuals had more than 4-fold higher odds of OAB and 30% higher odds of urinary incontinence. Vitamin D supplementation reduced urinary incontinence risk by 66% in the same meta-analysis. Vitamin D receptors are present in bladder muscle and pelvic floor tissue, and clinical supplementation has been shown to improve urinary symptoms.
Vitamin D deficiency is significantly more prevalent in Parkinson's disease patients than in healthy controls, with a meta-analysis of 63 studies confirming lower vitamin D levels and higher odds of deficiency in PD. Cohort data suggest sufficient vitamin D may reduce PD risk. Supplementation studies show modest, non-significant improvements in motor outcomes.
Vitamin D deficiency is highly prevalent in PCOS and associated with insulin resistance, menstrual irregularity, and metabolic dysfunction. Multiple RCTs and systematic reviews show vitamin D supplementation improves hormonal profiles, inflammation, and oxidative stress markers in PCOS, particularly when combined with calcium or other micronutrients.
Vitamin D is critical for bone health during perimenopause, as declining estrogen accelerates bone turnover. It is officially recommended by the European Menopause and Andropause Society, works synergistically with calcium to reduce osteoporosis risk, and is associated with improved mood, reduced inflammation, and support for vasomotor and immune function during the menopausal transition.
Vitamin D is consistently identified as one of the top three deficiencies in picky eaters, alongside iron and zinc. Picky eaters who avoid dairy, fatty fish, and fortified foods are at heightened risk. Clinical trials of oral nutritional supplementation in picky eating children show significant reduction in vitamin D inadequacy.
Low vitamin D levels are associated with increased PMS risk and severity; PMS has been characterised as a calcium/vitamin D deficiency state that is unmasked during the luteal phase. RCTs of combined calcium and vitamin D show significant PMS symptom reduction, and a high-dose vitamin D3 trial showed reductions in PMS incidence.
Vitamin D has RCT evidence for reducing time to improvement in severe pneumonia in vitamin D-deficient children given a high-dose (100,000 IU). Meta-analyses establish vitamin D deficiency as an independent risk factor for pneumonia. Supplementation reduces acute respiratory tract infection incidence in deficient populations and is studied in Cochrane reviews for COVID-19 pneumonia.
Observational data show a protective association between vitamin D supplementation and high-risk colorectal adenoma (OR 0.57 in one study). A 2019 study confirmed 25-hydroxyvitamin D deficiency in nasal polyposis; 4,000 IU/day post-surgery has been associated with reduced nasal polyp recurrence. However, the Vitamin D/Calcium Polyp Prevention Study (n=2,259, 3–5 years) and the VITAL trial (n=25,871) both failed to show significant reduction in colorectal adenoma recurrence with vitamin D supplementation.
Vitamin D modulates both innate and adaptive immunity and has been documented to be deficient in many patients during and after respiratory illness. Supplementation has been shown to reduce risk of acute respiratory infections in a large meta-analysis, and replenishing deficiency is a key component of post-illness recovery protocols.
Vitamin D plays an immune-modulating role in upper respiratory mucosal defense and has been studied clinically as adjunctive treatment for chronic sinusitis and rhinitis-associated post-nasal drip. A 2023 RCT (PMC10142908, n=60) found a supplement containing vitamin D and Boswellia significantly reduced rhinorrhea in chronic sinusitis versus nasal steroid alone. Vitamin D deficiency is associated with increased severity of allergic rhinitis and sinusitis.
Vitamin D supplementation, particularly at high doses perioperatively, significantly improves muscle strength and functional outcomes after orthopedic surgeries including hip and knee replacements. A 2025 systematic review (10 studies) found high-dose perioperative vitamin D notably enhances post-surgical muscle recovery and functional outcomes.
Vitamin D deficiency is common in long COVID patients and has been linked to worse post-viral outcomes. Clinical studies show supplementation reduces inflammatory markers (CRP) and supports immune recovery. A systematic review confirmed 50,000 IU/month vitamin D showed efficacy in reducing CRP relevant to post-viral inflammation. Studies have found many post-COVID fatigue patients are deficient in vitamin D.
Vitamin D deficiency is highly prevalent in the postpartum period, particularly in breastfeeding women, and is linked to impaired mood, immune function, bone health, and wound healing. A 2019 RCT (95 mother-infant pairs) found maternal supplementation of 6,000 IU/day postpartum significantly improved both maternal and infant vitamin D status. A 2022 narrative review found >90% of breastfeeding infants of supplemented mothers achieved adequate vitamin D levels.
Vitamin D is among the most studied prenatal micronutrients, essential for calcium absorption, fetal skeletal development, immune function, and fetal brain development. Severe deficiency causes maternal and fetal rickets; observational and RCT evidence links deficiency to gestational diabetes, preeclampsia, preterm birth, and neurodevelopmental disorders in offspring. Vitamin D insufficiency affects up to 47.9% of individuals globally, with especially high rates in pregnant women. WHO, ACOG, and NICE all give conditional-to-strong recommendations for prenatal supplementation.
Vitamin D deficiency is strongly associated with psoriasis severity, and vitamin D supplementation has been evaluated in multiple RCTs. A 2023 systematic review and meta-analysis found that oral vitamin D supplementation improved PASI scores in psoriasis patients, with subgroup analyses showing stronger effects in Asian populations and with vitamin D2 supplementation.
Multiple RCTs and a 2025 systematic review in the European Journal of Medical Research demonstrate that vitamin D deficiency is linked to chronic urticaria, with supplementation showing symptom improvement. A prospective case-control study (60 CSU patients) confirmed vitamin D supplementation improved hives symptoms and quality of life. Vitamin D modulates mast cell stability and reduces histamine release.
Vitamin D modulates immunity by suppressing Th17 cells, reducing IL-17 and pro-inflammatory cytokines central to RA. Multiple meta-analyses document low vitamin D levels in RA patients, and systematic reviews of RCTs show vitamin D supplementation improves disease activity scores, pain, and inflammatory markers in RA.
Vitamin D status is altered in rosacea patients, with deficiency linked to severity. Multiple studies examined vitamin D and cathelicidin in rosacea (Park et al. Ann Dermatol 2018; Ekiz et al. Cutan Ocul Toxicol 2014). The Archives of Dermatological Research 2024 systematic review assessed vitamin D in rosacea, though outcomes varied across studies.
Vitamin D deficiency is strongly linked to musculoskeletal and neuropathic pain including sciatica. Vitamin D reduces nerve inflammation, supports calcium absorption for cartilage and bone health, and modulates immune responses relevant to nerve root irritation. Multiple authoritative clinical reviews identify vitamin D as a key nutrient in sciatica management.
Low serum vitamin D levels are commonly found in people with SAD and are directly associated with reduced sunlight exposure in winter. NCCIH explicitly lists vitamin D among complementary approaches studied for SAD. A 1999 trial (n=15) found vitamin D comparable to phototherapy; however, a 2014 RCT (n=34) and a 2006 RCT (n=2,117) failed to show significant benefit. Evidence is mixed, and NCCIH does not currently support vitamin D alone as an effective SAD treatment.
Vitamin D deficiency is associated with increased susceptibility to respiratory infections including sinusitis. A 2024 SAGE Open Medicine narrative review specifically identified vitamin D among supplements with 'growing positive evidence' for sinusitis. Vitamin D supports antimicrobial peptide production in nasal and sinus mucosa.
Vitamin D (calcitriol) acts as a steroid hormone in skin, regulating keratinocyte differentiation, proliferation, and apoptosis. Vitamin D deficiency is associated with impaired skin barrier function and accelerated aging. Topical calcipotriol and oral vitamin D supplementation have been studied in the context of skin health and photoaging, though direct RCT evidence for wrinkle reduction is limited.
Multiple meta-analyses demonstrate significantly lower serum 25(OH)D levels in OSA patients versus controls, with severity correlating inversely with vitamin D status. A 2025 multi-institutional retrospective cohort study found sustained vitamin D deficiency was associated with a 25–28% increased hazard ratio for developing OSA. Vitamin D receptors in respiratory muscles may influence upper airway dilator function and inflammatory pathways relevant to OSA.
Vitamin D functions as a steroid hormone and has direct effects on testosterone production via Leydig cell receptors. A systematic review of eight studies found a consistent positive association between vitamin D status and testosterone levels in adult males. Supplementation in vitamin D-deficient men has been shown in RCTs to increase total and free testosterone.
Vitamin D deficiency is considered a risk factor for autoimmune thyroid diseases including Hashimoto's thyroiditis and Graves' disease, and for thyroid cancer. Multiple studies show a negative association between serum 25(OH)D and anti-thyroid antibodies. Clinical studies of vitamin D supplementation in Hashimoto's patients consistently show reductions in anti-thyroid antibody levels.
A systematic review (2022) found vitamin D serum levels are consistently lower in TMD patients, and a retrospective multi-center cohort study found deficient 25(OH)D levels associated with 50% increased TMD incidence risk. A double-blind placebo-controlled RCT found vitamin D supplementation plus splint therapy significantly improved comfort mouth opening, maximum mouth opening, and pain scores in vitamin D-deficient TMD patients.
Vitamin D facilitates calcium absorption and utilization, and vitamin D receptors on ameloblasts and odontoblasts indicate a direct role in tooth mineralization. Deficiency is associated with increased caries risk and impaired enamel remineralization. Ex vivo studies show topical fluoride plus vitamin D promotes mineral crystal formation on tooth enamel.
Vitamin D has robust evidence from a landmark 2017 BMJ meta-analysis (25 RCTs, n=11,321) finding supplementation significantly reduced acute respiratory infection incidence. It induces antimicrobial peptide production (cathelicidin/LL-37) against respiratory pathogens and modulates immune inflammatory responses during URTI.
Vitamin D plays an essential role in activating antiviral immune defenses by enhancing immune cell function, inducing antimicrobial peptides (cathelicidins and defensins), and modulating cytokine responses. Clinical supplementation protected against common cold overall, particularly in deficient individuals. Multiple trials support a role in reducing viral respiratory infection severity.
Volver